Polycystic ovary syndrome

A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Read more

Aliases

• Cystic disease of ovaries
• hyperandrogenemia
• Multicystic ovaries
• multicystic ovaries
• Ovarian Degeneration, Sclerocystic
• Ovarian Syndrome, Polycystic
• Ovarian Syndromes, Polycystic
• Ovaries, Sclerocystic
• Ovary Syndrome, Polycystic
• Ovary, Sclerocystic
• PCO - Polycystic ovaries
• Pco1
• PCOD - Polycystic ovarian disease
• PCOS
• Pcos
• PCOS - Polycystic ovarian syndrome
• PCOS1
• Polycystic ovarian disease
• polycystic ovarian disease
• Polycystic ovarian syndrome
• Polycystic ovaries
• polycystic ovaries
• Polycystic ovaries (disorder)
• polycystic ovary
• polycystic ovary syndrome
• polycystic ovary syndrome
• polycystic ovary syndrome 1
• Sclerocystic Ovarian Degeneration
• Sclerocystic Ovaries
• Sclerocystic Ovary
• Sclerocystic Ovary Syndrome
• Stein Leventhal Syndrome
• Stein-Leventhal synd.
• Stein-Leventhal Syndrome
• Stein-Leventhal syndrome
• Syndrome, Polycystic Ovary
• Syndrome, Stein-Leventhal

Studies related to Polycystic ovary syndrome Advanced search

Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling

Alteration in gut mycobiota of patients with polycystic ovary syndrome

Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals

Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China

Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome

Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia

Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome

Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine

Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome

Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome

Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome

Effect of the ketogenic diet on gut microbiome composition and metabolomics in polycystic ovarian syndrome rats induced by letrozole and a high-fat diet

Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention

Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice

Effects of inulin on intestinal flora and metabolism-related indicators in obese polycystic ovary syndrome patients

Effects of vaginal microbiota on in vitro fertilization outcomes in women with different infertility causes

Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study

Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet

Irisin alleviated the reproductive endocrinal disorders of PCOS mice accompanied by changes in gut microbiota and metabolomic characteristics

Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome

Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance

Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection

Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome

Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome

Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study

The efficacy and mechanism of Angelica sinensis (Oliv.) Diels root aqueous extract based on RNA sequencing and 16S rDNA sequencing in alleviating polycystic ovary syndrome

The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population

The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome

The interplay between PCOS pathology and diet on gut microbiota in a mouse model